Requip - Ropinirole - Dosage - Side Effects - Drug Interactions - Warnings

Requip (ropinirole) drug information, dosage, side effects, drug interactions, and warnings. Requip, generic drug name ropinirole, is a dopamine agonist. Requip is approved to treat signs and symptoms of Parkinson’s disease and restless legs syndrome.

• Drugs A-Z - Requip / Ropinirole

Requip (ropinirole) Approved by FDA for Restless Legs Syndrome

Requip (ropinirole) has been approved by the U.S. Food and Drug Administration to treat moderate to severe Restless Legs Syndrome (RLS). Requip was first approved in 1997 to treat Parkinson’s disease. RLS is characterized by an urge to move the legs, usually accompanied by or caused by uncomfortable leg sensations. Typically symptoms begin or worsen during periods of rest or inactivity and are partially or totally relieved by movement.

• FDA Approves Requip for Restless Legs Syndrome

Related Resources:

• Is Restless Legs Syndrome (RLS) Chronic or Treatable?
• Guide To Restless Legs Syndrome
• In-Depth Report: Restless Legs Syndrome
• More About Restless Legs Syndrome